FDA inspection
Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical: FDA inspection ending Dec 20, 2019
FDA inspection 1114178 · Los Angeles, CA
Key facts
| Inspection ID | 1114178 |
|---|---|
| Firm | Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical |
| FEI number | 3013341563 |
| Address | 1990 Westwood Blvd Ste 135 |
| City | Los Angeles |
| State | CA |
| ZIP | 90025-4650 |
| Fiscal year | 2020 |
| Inspection end date | Dec 20, 2019 |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data